Omeros Corporation's stock surges as narsoplimab data shows 68% lower death risk in HSCT-TMA patients. Click to learn about the potential and risks of OMER stock.
Olly Murs has had to cancel one of his performances due to being advised to rest following a throat infection. The show, ...
Graphic designer, art director, record producer, advertiser, and photographer: Gianni Sassi revolutionised the relationship ...
Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review ...
HotCopper.com on MSN3h
Cambium jumps 43% as FDA approves Phase 3 trial for Elate OcularCambium Bio (ASX:CMB) has flagged approval from the U.S. FDA for phase three of a clinical trial using its Elate Ocular ...
OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced the formation of subsidiary OS Drug Conjugates (OSDC) ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesKey biosimilar value driver contributes to Sandoz global growth strategy ...
Despite the loss, Daisy Lubbers had a strong night on the court, with 11 points and 12 rebounds. She was followed by Wingo ...
Mr. Chone Sophonpanich, President and Chief Executive Officer of Bangkok Life Assurance Public Company Limited, revealed that ...
Daily Times(PK) on MSN14h
The ISKP ThreatThree and half years of IAG’s rule in Kabul is marked with nothing but chaos, instability, infighting between different groups, strained relations with neighbours and last but not least, its failure ...
General Ibrahim Babangida grabbed the headlines when he launched his autobiography, Journey in Service. With the criticisms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback